Crucial Innovations (CINV) 10-Q2024 Q1 Quarterly report

Filed: 18 Feb 25, 1:41pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: absence, agent, alongside, amortized, annum, arrangement, attract, average, award, Bearded, bearing, British, broadly, Budz, Cannabudgrow, case, CCP, Circle, claim, component, conflict, continental, counsel, creditor, Crop, Deed, defense, discontinuation, discontinue, Dispensary, duration, employee, encouraging, endorse, enhance, entertainer, entirety, equal, equivalent, exclusive, exempt, exercise, exercised, expire, extent, fact, fall, fee, Fifty, formulating, fullest, genetic, hereinafter, holder, Hundred, imputed, Incentive, indemnification, indemnitee, input, Inspire, institutional, joint, jointly, Jumpstart, Kg, law, lieu, lower, maximum, minimum, Mir, month, multiplied, musician, negotiating, optimizing, paragraph, partnership, person, Pharma, pharmacy, Pound, previously, procurement, producing, production, promote, proprietary, quantity, question, raw, request, resume, retain, ROU, serving, solicitation, strategic, subscription, superseded, terminate, termination, Territory, unaffiliated, underwriting, undesignated, unreasonably, unrelated, unrestricted, Usman, vendor, venture, view, weighted, whichever, withheld, WLR

Removed: accretion, ASU, Eco, embedded, fixed, incorporation, incur, longer, occurred, organization, registrant, repay, Rule, smaller, specifically, submitted, trade

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CINV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)

In connection with the accompanying Quarterly Report of Crucial Innovations Corp. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024 (the “Report”), I, Darlington Ganda, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

To my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 18, 2025

	CRUCIAL INNOVATIONS CORP.

	/s/ Darlington Ganda
	Darlington Ganda
	Chief Financial Officer